Likmeta, M. (2015) “CHRONIC HEPATITIS C WITH SIGNIFICANT MORBIDITY AND END-ORGAN DAMAGE DEVELOPMENT DURING PEG-INTERFERON ALPHA-2A/RIBAVIRIN THERAPY”, European Scientific Journal, ESJ, 11(18). Available at: https://test.eujournal.org/index.php/esj/article/view/5824 (Accessed: 19 April 2025).